Thus, based on the combined results from the gain- and loss-of-function approaches in vivo and in vitro, we concluded that the upregulated TRAF3 expression in hepatocytes functions as a positive regulator of HFD-induced obesity and insulin resistance. Here, TRAF3 is linked to obesity due to melanocortin 4 receptor deficiency.